President & CEO
Ms. Shunee Yee is the President and CEO of CSOFT International, a leading global communications and localization company. Responsible for its organic growth from a start-up in a two-bedroom apartment, to becoming an industry leader, Yee oversees CSOFT’s operations across 16 offices and 3 continents.
Ms. Yee has been recognized for her many contributions in the sphere of education including to the Johns Hopkins US-China Studies Nanjing Center for its cross-cultural program as well as to Michelle Obama’s Let Girls Learn initiative, where CSOFT worked on translating enhanced gender training literature for the Peace Corps from English into multiple languages, helping the Obama Administration reach 62 million girls worldwide.
In June 2016, Ms. Yee led CSOFT into a partnership with the Shenzhen Municipal Government and launched the Shenzhen 100 research report, which assists the government in implementing effective policies to support global market strategies. Ms. Yee sits on Dexter Southﬁeld School’s Academic Board, and she is a Committee member of A Taste of Ginger, an event hosted by the world-renowned Joslin Center, for promoting awareness and education in support of the Asian American Diabetes Initiative.
Head Scientific Advisor, CSOFT Health Sciences
Professor Elegant is a physician who joined the pharmaceutical industry after postgraduate training in obstetrics and gynecology in the UK. She has held positions in global drug development, medical affairs, regulatory affairs and drug safety in Japan, Australia, Europe and Asia Pacific. She joined Amgen in October 2016 and is Vice-President, JAPAC Regional Medical Head, based in Hong Kong.
Professor Elegant is actively engaged in the training and education of physicians in the healthcare industry. She was involved with establishing the first postgraduate training course for pharmaceutical physicians in Australia. Dr. Elegant is a Fellow of the Faculty of Pharmaceutical Medicine, a member of the FPM International Committee, and is currently working on training programs in the Asia-Pacific region. She is on the Board of Studies for the Masters in Pharmaceutical Medicine, UNSW. She is a founding member of the China Medical Affairs Network. She is on the board of the Medical Affairs Professional Society, and is Adjunct Professor, Faculty of Medicine, University of New South Wales, Sydney Australia.
Professor Elegant is passionate about promoting diversity and inclusion, especially in supporting women leadership. She was involved in Building Talent Edge, a Catalyst Award-winning program supporting women in Baxter Healthcare and leading to a 50:50 men:women ratio at the senior manager level and above across the Asia-Pacific region.
Diego Di Leva
Vice President, Global Operations & Strategic Partnership
Originally from Italy, Diego Di Leva is the VP of Global Language Resources. In this role, Diego leads teams responsible for executing end-to-end project management and supply chain strategy.
Chief Life Science Practice Lead & Executive Director, CSOFT Health Sciences
Di Lv has worked in the international healthcare market for the past 8 years. With a deep understanding of China’s healthcare and regulations, Di received her first law degree in China and then pursued further studies in the UK obtaining a second law degree with a focus in human rights.
Placing high value on continued educational development, she earned a second M.S. degree in management. Entering the healthcare market in 2010, Di first worked in the drug discovery field. Her work took her to Belgium and Germany as a Business Development Manager, calling on clinical institutions, medical schools, and pharmaceutical companies.
Scientific Advisor, CSOFT Health Sciences
Li Chenjian is a principal investigator at the IDG McGovern Institute for Brain Research and Associate Dean of the School of Life Sciences at Peking University. His research in neuroscience and drug development has led to significant insights into the mechanisms of neurodegenerative diseases.
Chief Strategist, China Market Access
With more than 14 years of experience working with international pharmaceutical programs in anti-infective, cardiovascular, endocrine, and nutritional products at companies including Xi‘an Janssen, Novartis Pharmaceuticals, and Mead Johnson (China), Dr. Wang has participated in Asian market registration, clinical research, and market access projects of many important domestic drug varieties.
Dr. Wang entered the field of translational research in 2013. He headed the Foshan Industrial Technology Research Institute of the Chinese Academy of Sciences’ pharmaceutical project and established strong commercialization partnerships with the Chinese Academy of Sciences and Peking University.
Dr. Wang holds a degree in Pharmacy from the Peking University Health Science Center and was Vice Chairman of the Student Union at the Center.